COVID-19 vaccination and boosting during pregnancy protects infants for six months
COVID-19 vaccination and boosting during pregnancy protects infants for six months Transmission electron micrograph of…
News Releases
News Releases
Long-acting HIV treatment demonstrates efficacy in people with challenges taking daily medicine as prescribed
Long-acting HIV treatment demonstrates efficacy in people with challenges taking daily medicine as prescribed Transmission…
News Releases
Tools underestimate cardiovascular event risk in people with HIV
Tools underestimate cardiovascular event risk in people with HIV NIH trial reveals need for more…
News Releases
Semaglutide reduces severity of common liver disease in people with HIV
Semaglutide reduces severity of common liver disease in people with HIV NIH-funded findings inform interdisciplinary…
News Releases
Vaginal ring and oral pre-exposure prophylaxis found safe for HIV prevention throughout pregnancy
Vaginal ring and oral pre-exposure prophylaxis found safe for HIV prevention throughout pregnancy Multi-country findings…
News Releases
Children surpass a year of HIV remission after treatment pause
Children surpass a year of HIV remission after treatment pause NIH-funded trial shows promising outcomes…
News Releases
Inflammation-reducing drug shows no benefit for dry age-related macular degeneration in NIH trial
Inflammation-reducing drug shows no benefit for dry age-related macular degeneration in NIH trial Retina, showing…
News Releases
Experimental gene therapy for giant axonal neuropathy shows promise in NIH clinical trial
Experimental gene therapy for giant axonal neuropathy shows promise in NIH clinical trial Treatment for…
News Releases
Drug shows promise for slowing progression of rare, painful genetic disease
Drug shows promise for slowing progression of rare, painful genetic disease NIH-supported clinical trial could…
News Releases
Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard regimen
Lower dose of mpox vaccine is safe and generates six-week antibody response equivalent to standard…